Article
Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
Respirology (Carlton, Vic.) - 1 Oct 2013
Kabata Hiroki, Satoh Toru, Kataoka Masaharu, Tamura Yuichi, Ono Tomohiko, Yamamoto Miyuki, Huqun, Hagiwara Koichi, Fukuda Keiichi, Betsuyaku Tomoko, Asano Koichiro
Abstract excerpt
BACKGROUND AND OBJECTIVE: Mutation of bone morphogenetic protein receptor type 2 (BMPR2) is a cause of pulmonary arterial hypertension (PAH). We measured the prevalence of this mutation and its impact on the phenotypes and long-term clinical outcomes in Japanese patients. METHODS: Between 1999 and 2007, we consecutively enrolled and, until March 2012, followed 49 Japanese patients with PAH, including nine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
